Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Tirzepatide May Be Right for You If You have a BMI of 30 or higher, or 27 or higher with a weight-related health condition You want an FDA-approved medication with well-established clinical evidence You have type 2 diabetes and want to address both blood sugar and weight You prefer a treatment with extensive real-world safety data You have responded well to GLP-1 medications in the past and want enhanced results Retatrutide May Be Worth Discussing If You have significant weight to lose and want a more aggressive metabolic approach Previous dual-agonist or single-agonist therapies have plateaued You are interested in emerging therapies and are comfortable with newer clinical data You have concerns about fatty liver disease, given retatrutides potential hepatic benefits You want a treatment that addresses both appetite suppression and energy expenditure Important Medical Considerations Neither medication is appropriate for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
is a U.S
Older adults Age-related considerations include potentially slower response times requiring longer protocols, importance of medical supervision given likely concurrent health conditions, possible interactions with age-related medications, and conservative dosing approaches initially
That delayed gastric emptying is part of why these medications work so well for weight loss
Impurities can not only render the peptide inert but also introduce confounding variables and unwanted side effects
Concerns about bone loss with GLP-1s come up often, yet the evidence consistently shows either preservation or slight gains in bone density
